Weijun Fu

1 clinical trials · Sponsor

Record	Firm	Date
A Single-center Exploratory Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of a BCMA-targeted Universal LCAR-BCX Cells in Patients With Relapsed/Refractory Multiple Myeloma (NCT04601935)	Weijun Fu	2020-10-09

Every clearance here is in the API, with alerts when new ones post.